National Law Review December 1, 2021
Lisa M. Noller, Lori A. Rubin, Lauren P. Carboni, Kara Schoonover

When a company decides to self-disclose misconduct (or conduct that may be construed as such) to the government, that decision triggers a stream of additional questions. In the weighty deliberations about whether and what to disclose, entities often overlook another important decision: where to disclose.

On November 8, 2021, OIG-HHS updated its Provider Self Disclosure Protocol, including a name change to Health Care Fraud Self Disclosure Protocol (OIG-SDP or Protocol). The majority of the updates were technical in nature and did not change the substance of the Protocol. Foley’s top observations from the updated OIG-SDP can be found here.

The decision whether to self-disclose misconduct through the OIG-SDP is not to be taken lightly. Indeed, many providers, entities, suppliers, etc....

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, OIG, Provider, Regulations
Family physicians ready to try AI in practice
ATA Action Raises Concerns Over DEA Telemedicine Proposed Rule
California ASCs fight payment cuts, staffing woes
The Perfect Storm facing the Healthcare Workforce: Eight Current Issues frame the Challenge
Clinical AI platform to be trained on 30 years of NEJM archives

Share This Article